Cancer News: Cellceutix (CTIX) Updates Shareholders on Kevetrin™

Cancer News: Cellceutix Updates Shareholders on Kevetrin™

Cellceutix Corporation (OTCQB:CTIX) provided shareholders with an update on the status of the Investigational New Drug filing for Kevetrin™, their lead compound as an indication for a variety of cancers. The Company has met with world-class cancer centers regarding hosting the clinical trials for Kevetrin™, a completely novel cancer therapy with strong pre-clinical data as a treatment for several strains of cancer including pancreatic, lung, breast and colon, and is now awaiting replies from the institutions. Read the full press release and get CTIX stock quote.

Facebook page now open. Take a moment to Like us.

0 comments

Add your comment

Commenting is allowed only for registered users.

Other articlesgo to homepage

	Markets Take Another Pounding(0) U.S. stocks were lower for a fifth day Thursday, as investors continued to fret about Greece”s future in the euro-zone. The Dow Jones Industrials closed down 156.06 points, or 1.2%, to 12,442.50 The S&P 500 demurred 19.94 points to 1,304.86. The tech-rich Nasdaq Composite Index capsized 60.35 to 2,813.69. Retail giants Wal-Mart and Sears Holdings

	Winning Brands Gets First Order from Canada(0) Winning Brands Corporation (Pink Sheets: WNBD) reported that it has received its first order for delivery of 1000+™ Stain Remover, World’s Most Versatile Cleaning Solution™, to a military facility, in Canada. 1000+ is manufactured by the Niagara Mist Marketing Division of Winning Brands. The first order is for product to be used at a Canadian

	Premiere Opportunities Partners with Flex Fuel Technologies(0) Totowa, New Jersey-based Premiere Opportunities Group, Inc. (OTCQB: PPBL) has signed an advisory agreement with Flex Fuel Technologies Inc. to assist the company with its strategic planning, EPA testing and budget planning for the future introduction of its products into the automotive aftermarket. Flex Fuel Technologies, Inc. has developed a ” bolt on technology,” called

	Pioneers in Regenerative Medicine Reshaping the Landscape of Biotechnology(0) Every industry or sector has pioneers that worked at the forefront of the field to shepherd new technologies into the mainstream. Oncology, for example, took huge steps forward as a result of the efforts of Dr. Sidney Farber, earning him the titles of “the father of the modern era of chemotherapy” and “father of modern

	Overhyped Social Media Stocks Highlight Value in CrowdGather(0) There is a lot of activity surrounding social media stocks with the Initial Public Offering of Facebook (NASDAQ: FB) coming on Friday. The new listing, which could see the company valued at as much as $100 billion, has investors and analysts already concerned that the world’s largest social network could be overvalued from the get-go.

Stay Informed

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Cancer News: Cellceutix Updates Shareholders on Kevetrin™

0 comments

Add your comment

Other articlesgo to homepage

Markets Take Another Pounding(0)

Winning Brands Gets First Order from Canada(0)

Premiere Opportunities Partners with Flex Fuel Technologies(0)

Pioneers in Regenerative Medicine Reshaping the Landscape of Biotechnology(0)

Overhyped Social Media Stocks Highlight Value in CrowdGather(0)

OTCBB News

Stay Informed

Dana-Farber to Host Cellceutix Trials

Diabetes Rate Growing Exponentially

Gateways

Contacts and information

Social networks

Most popular categories